• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国 2020 年胃食管反流病医学管理指南。

Thailand guideline 2020 for medical management of gastroesophageal reflux disease.

机构信息

Division of Gastroenterology, Department of Internal Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

J Gastroenterol Hepatol. 2022 Apr;37(4):632-643. doi: 10.1111/jgh.15758. Epub 2022 Jan 25.

DOI:10.1111/jgh.15758
PMID:34907597
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9303339/
Abstract

Gastroesophageal reflux disease (GERD) is one of the most prevalent and bothersome functional gastrointestinal disorders worldwide, including in Thailand. After a decade of the first Thailand GERD guideline, physician and gastroenterologist encountered substantially increase of patients with GERD. Many of them are complicated case and refractory to standard treatment. Concurrently, the evolution of clinical characteristics as well as the progression of investigations and treatment have developed and changed tremendously. As a member of Association of Southeast Asian Nations, which are developing countries, we considered that the counterbalance between advancement and sufficient economy is essential in taking care of patients with GERD. We gather physicians from university hospitals, as well as internist and general practitioners who served in rural area, to make a consensus in this updated version of GERD guideline focusing in medical management of GERD. This clinical practice guideline was constructed adhering with standard procedure. We categorized the guideline in to four parts including definition, investigation, treatment, and long-term follow up. We anticipate that this guideline would improve physicians' proficiency and help direct readers to choose investigations and treatments in patients with GERD wisely. Moreover, we wish that this guideline would be applicable in countries with limited resources as well.

摘要

胃食管反流病(GERD)是全球最常见和最令人困扰的功能性胃肠道疾病之一,包括在泰国。在第一个泰国 GERD 指南发布十年后,医生和胃肠病学家遇到了大量 GERD 患者。他们中的许多人是复杂的病例,对标准治疗有反应。同时,临床特征的演变以及调查和治疗的进展发生了巨大的变化。作为东南亚国家联盟(东盟)的成员国,我们是发展中国家,我们认为在照顾 GERD 患者时,在进步和足够的经济之间取得平衡至关重要。我们召集了来自大学医院的医生,以及在农村地区服务的内科医生和全科医生,就 GERD 指南的这一更新版本达成共识,重点关注 GERD 的医学管理。本临床实践指南是按照标准程序制定的。我们将指南分为四个部分,包括定义、调查、治疗和长期随访。我们期望本指南能够提高医生的专业水平,并帮助读者明智地选择 GERD 患者的检查和治疗方法。此外,我们希望本指南也适用于资源有限的国家。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0b/9303339/a10051d07d21/JGH-37-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0b/9303339/90a6eb46d149/JGH-37-632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0b/9303339/a10051d07d21/JGH-37-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0b/9303339/90a6eb46d149/JGH-37-632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b0b/9303339/a10051d07d21/JGH-37-632-g002.jpg

相似文献

1
Thailand guideline 2020 for medical management of gastroesophageal reflux disease.泰国 2020 年胃食管反流病医学管理指南。
J Gastroenterol Hepatol. 2022 Apr;37(4):632-643. doi: 10.1111/jgh.15758. Epub 2022 Jan 25.
2
Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire Survey.亚洲国家胃食管反流病的管理:问卷调查结果。
Digestion. 2020;101(1):66-79. doi: 10.1159/000504749. Epub 2019 Dec 4.
3
Gastroesophageal reflux: management guidance for the pediatrician.胃食管反流病:儿科医生管理指南。
Pediatrics. 2013 May;131(5):e1684-95. doi: 10.1542/peds.2013-0421. Epub 2013 Apr 29.
4
[Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].[共识会议建议在耳鼻喉科、呼吸科或胸痛症状面前的应用,这些症状被认为是由胃食管反流病引起的]
Presse Med. 2013 May;42(5):e125-32. doi: 10.1016/j.lpm.2012.11.006. Epub 2013 Feb 13.
5
API-ISG Consensus Guidelines for Management of Gastrooesophageal Reflux Disease.《美国胃肠病学会-美国感染病学会胃食管反流病管理共识指南》
J Assoc Physicians India. 2020 Oct;68(10):69-80.
6
Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.胃食管反流病:夸大之处、证据与临床实践
J Pediatr (Rio J). 2014 Mar-Apr;90(2):105-18. doi: 10.1016/j.jped.2013.05.009. Epub 2013 Oct 30.
7
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.美国胃肠病学会胃食管反流病诊断和管理临床指南
Am J Gastroenterol. 2022 Jan 1;117(1):27-56. doi: 10.14309/ajg.0000000000001538.
8
ESNM/ANMS consensus paper: Diagnosis and management of refractory gastro-esophageal reflux disease.ESNM/ANMS 共识文件:难治性胃食管反流病的诊断和治疗。
Neurogastroenterol Motil. 2021 Apr;33(4):e14075. doi: 10.1111/nmo.14075. Epub 2020 Dec 28.
9
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.《2015年胃食管反流病循证临床实践指南》
J Gastroenterol. 2016 Aug;51(8):751-67. doi: 10.1007/s00535-016-1227-8. Epub 2016 Jun 21.
10
National consensus on the management of gastroesophageal reflux disease in Indonesia.印度尼西亚关于胃食管反流病管理的全国共识。
Acta Med Indones. 2014 Jul;46(3):263-71.

引用本文的文献

1
Comparable efficacy of generic and original alginate for symptom control in PPI-refractory GERD.仿制药与原研藻酸盐在控制质子泵抑制剂难治性胃食管反流病症状方面疗效相当。
Sci Rep. 2025 Aug 4;15(1):28429. doi: 10.1038/s41598-025-13400-w.
2
Efficacy and safety of Jianpi Qinghua granules for non-erosive reflux disease with spleen deficiency and damp-heat syndrome: a multicenter, randomized, double-blind, placebo-controlled clinical trial.健脾清化颗粒治疗脾虚湿热型非糜烂性反流病的疗效与安全性:一项多中心、随机、双盲、安慰剂对照临床试验
Front Nutr. 2025 Jan 7;11:1509931. doi: 10.3389/fnut.2024.1509931. eCollection 2024.
3
Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease.

本文引用的文献

1
Clinical Presentation of Gastroesophageal Reflux Disease: A Prospective Study on Symptom Diversity and Modification of Questionnaire Application.胃食管反流病的临床表现:一项关于症状多样性和问卷应用修正的前瞻性研究。
Dig Dis. 2020;38(3):188-195. doi: 10.1159/000502796. Epub 2019 Sep 12.
2
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.一项评估沃诺拉赞对比兰索拉唑在亚洲糜烂性食管炎患者中的疗效和安全性的 III 期、随机、双盲、多中心研究。
Gut. 2020 Feb;69(2):224-230. doi: 10.1136/gutjnl-2019-318365. Epub 2019 Aug 13.
3
钾离子竞争性酸阻滞剂与胃食管反流病
Gastroenterol Hepatol (N Y). 2023 May;19(5):295-298.
4
Trends in gastroesophageal reflux disease research: A bibliometric and visualized study.胃食管反流病研究趋势:一项文献计量学与可视化研究
Front Med (Lausanne). 2022 Sep 29;9:994534. doi: 10.3389/fmed.2022.994534. eCollection 2022.
Risk factors associated with oral manifestations and oral health impact of gastro-oesophageal reflux disease: a multicentre, cross-sectional study in Pakistan.
与胃食管反流病口腔表现和口腔健康影响相关的风险因素:巴基斯坦的一项多中心、横断面研究。
BMJ Open. 2019 Mar 30;9(3):e021458. doi: 10.1136/bmjopen-2017-021458.
4
Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.系统评价与网络荟萃分析:沃诺拉赞与质子泵抑制剂治疗胃食管反流病维持治疗的间接比较。
J Gastroenterol. 2019 Aug;54(8):718-729. doi: 10.1007/s00535-019-01572-y. Epub 2019 Mar 27.
5
Vonoprazan versus proton-pump inhibitors for healing gastroesophageal reflux disease: A systematic review.Vonoprazan 与质子泵抑制剂治疗胃食管反流病的疗效比较:系统评价。
J Gastroenterol Hepatol. 2019 Aug;34(8):1316-1328. doi: 10.1111/jgh.14664. Epub 2019 Apr 11.
6
Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD.重温蒙特利尔共识:症状及其病因的新见解,以及对 GERD 未来的影响。
Am J Gastroenterol. 2019 Mar;114(3):414-421. doi: 10.1038/s41395-018-0287-1.
7
On-Demand Therapy with Proton Pump Inhibitors for Maintenance Treatment of Nonerosive Reflux Disease or Mild Erosive Esophagitis: A Systematic Review and Meta-Analysis.质子泵抑制剂按需治疗用于非糜烂性反流病或轻度糜烂性食管炎维持治疗的系统评价和荟萃分析
Gastroenterol Res Pract. 2018 Aug 12;2018:6417526. doi: 10.1155/2018/6417526. eCollection 2018.
8
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.愈合性糜烂性食管炎的维持治疗:沃诺拉赞与兰索拉唑的 III 期比较。
World J Gastroenterol. 2018 Apr 14;24(14):1550-1561. doi: 10.3748/wjg.v24.i14.1550.
9
Modern diagnosis of GERD: the Lyon Consensus.现代 GERD 诊断:里昂共识。
Gut. 2018 Jul;67(7):1351-1362. doi: 10.1136/gutjnl-2017-314722. Epub 2018 Feb 3.
10
Expert consensus document: Advances in the physiological assessment and diagnosis of GERD.专家共识文件:胃食管反流病生理学评估和诊断的进展。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):665-676. doi: 10.1038/nrgastro.2017.130. Epub 2017 Sep 27.